Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo

Published:2018-04 Issue:4 Volume:22 Page:501-513.e7
ISSN:1934-5909
Container-title:Cell Stem Cell
language:en
Short-container-title:Cell Stem Cell

Author:

Kooreman Nigel G.,Kim Youngkyun,de Almeida Patricia E.,Termglinchan Vittavat,Diecke Sebastian,Shao Ning-Yi,Wei Tzu-Tang,Yi Hyoju,Dey Devaveena,Nelakanti Raman,Brouwer Thomas P.,Paik David T.,Sagiv-Barfi Idit,Han Arnold,Quax Paul H.A.,Hamming Jaap F.,Levy Ronald,Davis Mark M.,Wu Joseph C.

Funder

Korean R&D

California Institute of Regenerative Medicine (CIRM)

NIH

Publisher

Elsevier BV

Subject

Cell Biology,Genetics,Molecular Medicine

Reference54 articles.

1. Differential expression analysis for sequence count data;Anders;Genome Biol.,2010

2. Count-based differential expression analysis of RNA sequencing data using R and Bioconductor;Anders;Nat. Protoc.,2013

3. HTSeq—a Python framework to work with high-throughput sequencing data;Anders;Bioinformatics,2015

4. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors;Ben-Porath;Nat. Genet.,2008

5. Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines;Bock;Cell,2011

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hybrid nanovesicles comprising induced pluripotent stem cells and dendritic cell-derived exosomes enhance antitumor immunity;Chemical Engineering Journal;2024-09

2. Current Trends and Innovative Approaches in Cancer Immunotherapy;AAPS PharmSciTech;2024-07-24

3. Senescent cell-derived vaccines: a new concept towards an immune response against cancer and aging?;Aging;2024-06-26

4. Current and future immunotherapeutic approaches in pancreatic cancer treatment;Journal of Hematology & Oncology;2024-06-04

5. Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers;npj Vaccines;2024-05-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3